American Oriental Bioengineering
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Cash used in financing activities reached the amount of -$15,485,748 last year. Net change in cash is therefore -$45,530,830.
Cash Flow
| 2012 | -46.45M | 15.18M | -15.48M |
|---|
AOBI Cash Flow Statement (2012 – 2012)
| 2012 | |
|---|---|
Cash at beginning of period | 52.62M |
Operating activities | |
Net income | -59.71M |
| Adjustments to reconcile net income to cash generated by operating activities: | |
Depreciation and amortization | 12.02M |
Stock-based compensation expense | 2.80M |
| Deferred income tax benefit | 2.80M |
| Changes in operating assets and liabilities: | |
Accounts receivable, net | -2.57M |
Inventories | -4.24M |
Accounts payable | -6.36M |
Cash generated by operating activities | -46.45M |
Investing activities | |
Purchases Of Investments | -4.66M |
Investments In Property Plant And Equipment | -18.66M |
Acquisitions Net | 18.31M |
Cash generated by investing activities | 15.18M |
Financing activities | |
Common Stock Issued | 0 |
Payments for dividends | 0 |
Repurchases of common stock | -1.27M |
Repayments of term debt | -26.87M |
Cash used in financing activities | -15.48M |
Net Change In Cash | -45.53M |
Cash at end of period | 7.09M |